DISTRIBUTION AND ANTIMICROBIAL RESISTANCE CHARACTERISTICS OF PSEUDOMONAS SPP. ISOLATED FROM MILITARY HOSPITAL 103

Văn An Nguyễn, Thị Hồng Ngọc Nguyễn

Main Article Content

Abstract

Objective: Study the distribution and antimicrobial resistance characteristics of Pseudomonas spp. except Pseudomonas aeruginosa, which were isolated from patients at Military Hospital 103 from 2014 to 2022. Subject and methods: This was a descriptive study. The subject of the study was Pseudomonas spp. strains isolated from patients at Military Hospital 103 from 2014 to 2022. Results: A total of 58 strains of Pseudomonas spp. were isolated from 2014 to 2022. P. putida was the most common pathogenic species (63.8%). Pseudomonas spp. strains were mostly isolated from male patients (74.1%), patients ≥60 years old (43.8%), urine specimens (39.7%), and surgery departments (34.5%). Pseudomonas spp. had the highest sensitivity rate to Amikacin (64.8%), followed by Gentamycin (53.8%) and Tobramycin (52.0%). In contrast, the bacteria were the most resistant to antibiotics such as Trimethoprim/sulfamethoxazole (87.0%), Ticarcillin/clavulanic acid (78.7%), and Levofloxacin (72.0%). Conclusion: The study indicated that Pseudomonas spp. strains were mainly isolated from urine and specimens from respiratory tract. Pseudomonas putida was the most common bacterial species in the Pseudomonas genus except Pseudomonas aeruginosa. Pseudomonas spp. was the most resistant to Trimethoprim/sulfamethoxazole, Ticarcillin/clavulanic acid, and Levofloxacin and the most sensitive to Amikacin.

Article Details

References

Adesola Adejobi, et al., Antibiotic resistance pattern of Pseudomonas spp. from patients in a tertiary hospital in South-West Nigeria, Germs (2021) Jun; 11(2): 238–245.
2. Hüsnü Baykal, et al., Clinical features, risk factors, and antimicrobial resistance of pseudomonas putida isolates. Medicine (Baltimore). (2022) Dec 2; 101(48): e32145.
3. Chan Ho Cho and Sang-Bumm Lee, Comparison of clinical characteristics and antibiotic susceptibility between Pseudomonas aeruginosa and P. putida keratitis at a tertiary referral center: a retrospective study. BMC Ophthalmology (2018) 18:204
4. Richa Gupta, et al., Incidence of Multidrug-Resistant Pseudomonas Spp. in ICU Patients with Special Reference to ESBL, AMPC, MBL and Biofilm Production. J Glob Infect Dis. (2016) Jan-Mar; 8(1): 25–31
5. Amy L. Leber, Clinical Microbiology Procedures Handbook, 2016: ASM Press.
6. Clinical and Laboratory Standards Institute (CLSI), Performance Standards for Antimicrobial Susceptibility Testing 32nd ed. CLSI supplement M100. (2022).
7. Seong Eun Kim, et al., Nosocomial Pseudomonas putida Bacteremia: High Rates of Carbapenem Resistance and Mortality. Chonnam Medical Journal (2012); 48(2): 91-95.
8. Brittan S. Scales, et al., Microbiology, Genomics, and Clinical Significance of the Pseudomonas fluorescens Species Complex, an Unappreciated Colonizer of Humans. Clin Microbiol Rev. (2014) Oct; 27(4): 927–948.